Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-14 4:27 pm Purchase |
2024-09-30 | 13G | Zymeworks Inc. ZYME |
BIOTECHNOLOGY VALUE FUND L P | 4,607,935 6.500% |
4,607,935 (New Position) |
Filing History |
| 2024-11-14 4:26 pm Purchase |
2024-09-30 | 13G | CytomX Therapeutics, Inc. CTMX |
BIOTECHNOLOGY VALUE FUND L P | 8,089,795 9.990% |
1,386,906 (+20.69%) |
Filing History |
| 2024-11-14 4:26 pm Sale |
2024-09-30 | 13G | Lexicon Pharmaceuticals, Inc. LXRX |
BIOTECHNOLOGY VALUE FUND L P | 0 0.000% |
-24,435,632 (Position Closed) |
Filing History |
| 2024-11-14 4:24 pm Purchase |
2024-09-30 | 13G | Cullinan Oncology, Inc. CGEM |
BIOTECHNOLOGY VALUE FUND L P | 5,796,433 9.990% |
1,403,112 (+31.94%) |
Filing History |
| 2024-11-14 4:24 pm Sale |
2024-09-30 | 13G | Janux Therapeutics, Inc. JANX |
BIOTECHNOLOGY VALUE FUND L P | 0 0.000% |
-4,579,818 (Position Closed) |
Filing History |
| 2024-11-14 4:23 pm Sale |
2024-09-30 | 13G | IDEAYA Biosciences, Inc. IDYA |
BIOTECHNOLOGY VALUE FUND L P | 1,409,993 1.700% |
-2,069,050 (-59.47%) |
Filing History |
| 2024-11-14 4:22 pm Purchase |
2024-09-30 | 13G | Cidara Therapeutics, Inc. CDTX |
BIOTECHNOLOGY VALUE FUND L P | 703,126 9.990% |
703,126 (New Position) |
Filing History |
| 2024-11-14 4:21 pm Sale |
2024-09-30 | 13G | Delcath Systems, Inc. DCTH |
BIOTECHNOLOGY VALUE FUND L P | 1,041,667 3.600% |
-1,296,759 (-55.45%) |
Filing History |
| 2024-11-14 4:20 pm Sale |
2024-09-30 | 13G | Centessa Pharmaceuticals plc CNTA |
BIOTECHNOLOGY VALUE FUND L P | 0 0.000% |
-8,774,570 (Position Closed) |
Filing History |
| 2024-11-13 4:08 pm Purchase |
2024-09-30 | 13G | 4D Molecular Therapeutics, Inc. FDMT |
BIOTECHNOLOGY VALUE FUND L P | 7,382,642 14.200% |
3,375,229 (+84.22%) |
Filing History |
| 2024-11-12 5:27 pm Sale |
2024-11-07 | 13G | Third Harmonic Bio, Inc. THRD |
BIOTECHNOLOGY VALUE FUND L P | 2,372,933 5.300% |
-1,993,000 (-45.65%) |
Filing History |
| 2024-11-01 4:27 pm Purchase |
2024-10-25 | 13G | Septerna, Inc. SEPN |
BIOTECHNOLOGY VALUE FUND L P | 2,452,024 5.500% |
2,452,024 (New Position) |
Filing History |
| 2024-10-31 5:50 pm Unchanged |
2024-10-29 | 13G | Eledon Pharmaceuticals, Inc. ELDN |
BIOTECHNOLOGY VALUE FUND L P | 6,293,282 10.500% |
0 (Unchanged) |
Filing History |
| 2024-10-31 5:49 pm Purchase |
2024-09-30 | 13G | Eledon Pharmaceuticals, Inc. ELDN |
BIOTECHNOLOGY VALUE FUND L P | 6,293,282 15.900% |
1,966,572 (+45.45%) |
Filing History |
| 2024-10-29 4:32 pm Purchase |
2024-10-25 | 13D | Molecular Partners AG MOLN |
BIOTECHNOLOGY VALUE FUND L P | 9,888,592 24.500% |
1,192,387 (+13.71%) |
Filing History |
| 2024-10-21 9:00 pm Unchanged |
2024-10-17 | 13D | Inventiva S.A. IVA |
BIOTECHNOLOGY VALUE FUND L P | 8,545,499 9.800% |
0 (Unchanged) |
Filing History |
| 2024-10-08 6:48 pm Sale |
2024-10-04 | 13D | MoonLake Immunotherapeutics MLTX |
BIOTECHNOLOGY VALUE FUND L P | 19,751,284 31.400% |
-2,000,000 (-9.19%) |
Filing History |
| 2024-09-11 7:42 pm Sale |
2024-09-02 | 13G | Calliditas Therapeutics AB (publ) CALT |
BIOTECHNOLOGY VALUE FUND L P | 0 0.000% |
-6,260,311 (Position Closed) |
Filing History |
| 2024-08-23 4:34 pm Purchase |
2024-08-13 | 13G | Avalo Therapeutics, Inc. AVTX |
BIOTECHNOLOGY VALUE FUND L P | 967,299 9.990% |
967,299 (New Position) |
Filing History |
| 2024-08-19 6:48 pm Purchase |
2024-08-08 | 13G | Tenax Therapeutics, Inc. TENX |
BIOTECHNOLOGY VALUE FUND L P | 340,660 9.990% |
340,660 (New Position) |
Filing History |